Registration Strip Icon for charts 실시간 차트, 분석 도구 및 가격을 받으려면 등록하세요.

BETRF

BetterLife Pharma (QB) (BETRF)

BetterLife Pharma Inc (QB)
일자:
정렬 기준:
 검색 관련기사 보기:USOTC:BETRF
일자시간출처헤드라인심볼기업
2024/05/1505:00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:BETRFBetterLife Pharma Inc (QB)
2024/05/0622:00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:BETRFBetterLife Pharma Inc (QB)
2024/03/0605:41Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:BETRFBetterLife Pharma Inc (QB)
2024/01/0303:37Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:BETRFBetterLife Pharma Inc (QB)
2023/12/3004:00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:BETRFBetterLife Pharma Inc (QB)
2023/12/1902:13Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:BETRFBetterLife Pharma Inc (QB)
2023/12/0103:00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:BETRFBetterLife Pharma Inc (QB)
2023/09/3002:00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:BETRFBetterLife Pharma Inc (QB)
2023/09/2822:00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:BETRFBetterLife Pharma Inc (QB)
2023/09/0523:58Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:BETRFBetterLife Pharma Inc (QB)
2023/07/1400:00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:BETRFBetterLife Pharma Inc (QB)
2023/06/2906:05Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:BETRFBetterLife Pharma Inc (QB)
2023/06/2906:01Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:BETRFBetterLife Pharma Inc (QB)
2023/06/2906:00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:BETRFBetterLife Pharma Inc (QB)
2023/06/1005:01Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:BETRFBetterLife Pharma Inc (QB)
2023/06/0705:23Edgar (US Regulatory)Amended Annual and Transition Report (foreign Private Issuer) (20-f/a)USOTC:BETRFBetterLife Pharma Inc (QB)
2023/05/1022:00Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:BETRFBetterLife Pharma Inc (QB)
2023/04/2602:35Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:BETRFBetterLife Pharma Inc (QB)
2023/03/0904:24Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:BETRFBetterLife Pharma Inc (QB)
2023/03/0806:31Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:BETRFBetterLife Pharma Inc (QB)
2023/02/2823:01Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:BETRFBetterLife Pharma Inc (QB)
2023/01/1823:01Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:BETRFBetterLife Pharma Inc (QB)
2022/12/2323:01Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:BETRFBetterLife Pharma Inc (QB)
2022/12/0822:01Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:BETRFBetterLife Pharma Inc (QB)
2022/11/0907:01Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:BETRFBetterLife Pharma Inc (QB)
2022/09/2805:31Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:BETRFBetterLife Pharma Inc (QB)
2022/06/3002:22Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:BETRFBetterLife Pharma Inc (QB)
2022/06/0703:35Edgar (US Regulatory)Annual and Transition Report (foreign Private Issuer) (20-f)USOTC:BETRFBetterLife Pharma Inc (QB)
2022/06/0119:00Edgar (US Regulatory)Notification That Form 20-f Will Be Submitted Late (nt 20-f)USOTC:BETRFBetterLife Pharma Inc (QB)
2022/03/0503:21Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:BETRFBetterLife Pharma Inc (QB)
 검색 관련기사 보기:USOTC:BETRF